ORIENTBIO Inc. (002630) — Cash Flow Reinvestment Rate
ORIENTBIO Inc. (002630) has a Cash Flow Reinvestment Rate of 0.26x as of December 2025, reinvesting ₩467.25 Million (capex ₩452.25 Million plus investments ₩-15.00 Million) from operating cash flow of ₩1.77 Billion. Check 002630 cash flow quality index to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
ORIENTBIO Inc. Cash Flow Reinvestment Rate (2007–2025)
Historical reinvestment intensity for ORIENTBIO Inc. across 12 annual periods. Explore ORIENTBIO Inc. long-term investment intensity to see how much of total assets are deployed in long-term investments.
Annual Cash Flow Reinvestment Rate for ORIENTBIO Inc. (2007–2025)
Year-by-year capital reinvestment analysis for ORIENTBIO Inc.. For live market cap and broader valuation context, see ORIENTBIO Inc. market capitalisation.
| Year | Reinvestment Rate | Total Reinvested (KRW) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 7.67x | ₩5.77 Billion | ₩752.29 Million | ₩4.79 Billion | ▲ +2420.9% |
| 2024 | 0.30x | ₩1.14 Billion | ₩3.76 Billion | ₩925.25 Million | ▼ -98.1% |
| 2023 | 16.12x | ₩18.70 Billion | ₩1.16 Billion | ₩485.64 Million | ▲ +314.8% |
| 2022 | 3.89x | ₩9.14 Billion | ₩2.35 Billion | ₩2.21 Billion | ▲ +8953.9% |
| 2021 | 0.04x | ₩375.16 Million | ₩8.74 Billion | ₩256.16 Million | ▼ -99.7% |
| 2016 | 16.17x | ₩14.76 Billion | ₩912.43 Million | ₩14.46 Billion | ▲ +233.8% |
| 2015 | 4.84x | ₩7.77 Billion | ₩1.60 Billion | ₩5.11 Billion | ▼ 0.0% |
| 2014 | 4.85x | ₩10.51 Billion | ₩2.17 Billion | ₩10.43 Billion | ▲ +30.3% |
| 2013 | 3.72x | ₩18.94 Billion | ₩5.09 Billion | ₩18.94 Billion | ▲ +289.9% |
| 2011 | 0.95x | ₩2.97 Billion | ₩3.11 Billion | ₩2.97 Billion | ▲ +460.7% |
| 2010 | 0.17x | ₩1.59 Billion | ₩9.35 Billion | ₩1.59 Billion | ▼ -97.9% |
| 2007 | 8.11x | ₩12.30 Billion | ₩1.52 Billion | ₩12.30 Billion | — |